Agencies should show a sharper edge and say more clearly what they are good at.1

1 Bathen D. 2016

co.patient's focus is on patient relations.

Closer to the patient –
What is important to us

Improving patient care

Innovative medicinal products and new medical devices only improve patient care if patients use them correctly. This is why co.patient has developed effective strategies and tools that increase patients' understanding of and adherence to therapy – to improve patient care.

Closer cooperation between industry and patients

Patients and industry are both eager to improve patient care. It is therefore only logical to also cooperate directly with one another in order to achieve these goals. co.patient sees itself as a mediator that brings industry and patients together – to enable beneficial cooperations.

Full transparency

We want our customers to trust us. This is why we at co.patient promote a culture of complete openness and transparency, from the offer and the first project step up to the feedback discussion after the successful completion of the project – to ensure that you, as a client, always know what we are doing.


Working with patients is made more challenging by a number of regulations and laws that lead to reservations when it comes to the industry partnering with patients. From "Heilmittelwerbegesetz" to "FSA-Kodex": we keep track of everything for you – to ensure that you as a client are always on the safe side.

Maximum benefit for clients

As a provider of services, we can only survive in the long run if our performance is of value for our customers. Our work is agile, service-oriented and aligned to your processes – to achieve the best possible results for you as a client.

Our team

co.patient has an interdisciplinary team of doctors, healthcare scientists, marketing strategists and communication experts who have many years of experience in the fields of patient relations, patient communication and patient engagement – all with a genuine appreciation of the patients.

Dr. med. Marc Esser
Managing Director

Stefanie Boeckmann, Pharmacist
Director Patient Relations

Peter Jungblut
Senior Consultant Patient Relations (external)

Susanne Almut Wilmes
Public Relations Manager

Cécile Guyomard
Senior Trainer (external)

Hannes Fuß
Digital Expert (external)

Dr. Bastian Thaa
Senior Medical Writer

Dr. Juliane Schreier
Senior Medical Writer

Dr. Meike Janto
Senior Medical Writer

Dr. Alexander Boreham
Senior Patient Relations Consultant

Dr. Moritz Klinghardt
Senior Consultant Patient Relations

Dr. Michael Wördehoff
Senior Consultant Patient Relations

Michael Barth, M. Sc.
Senior Consultant Patient Relations

Dr. Christiane Ring
Medical Writer

Dr. Linda Sawade
Medical Writer

Dr. Mira Meyer-Ács
Medical Writer

Dr. med. Simone Breitkopf
Senior Consultant (external)

Janine Petters, M. Sc.
Medical Writer

Tatjana Lux, M. Sc.
Medical Writer

Lisa Kramer, M. Sc.
Medical Writer

Yuk Ting Phung
Junior Medical Writer

Laura Loke, B. Sc.
Project Manager

Emily Raspe
Art Director

Publications of our team members (selection)

  • Fischer C, Esser M. Strategien zur Verbesserung der Adhärenz. Pharma Relations 2020; 6(19):19-22
  • Esser M, Krischok K. Patientenzentrierung durch Partnering mit Patienten Pharma Relations 2019; 8(19):10-12
  • Esser M, Boreham A. Patient Journeys im Pharmamarketing. Patient Relations 2019;3(19):14-15
  • Esser M, Schreier J, Thaa B. Gesundheitsbezogene Lebensqualität in der frühen Nutzenbewertung: Stellenwert, Evidenznachweis und Auswertung aktueller Verfahren. Pharmazeutische Medizin 2018;20(2):68-75
  • Esser M, Schreier J, Thaa B. Lebensqualität in der frühen Nutzenbewertung. Market Access & Health Policy 2017; 7(5):26-28
  • Esser M, Schreier J. Visuelle Nutzenkommunikation. Market Access & Health Policy 2017; 7(1):28-29
  • Esser M. Placebo- und Nocebokommunikation in der Ästhetischen Chirurgie. Journal für Ästhetische Chirurgie 2016; 9(2):74-76
  • Esser M. Storytelling: Mehrdimensionale Inhalte statt eindimensionale Werbung. PM-Report 2016; 35(4):18-19
  • Esser M, Guyomard C. Patientenkommunikation: Wie Pharmaunternehmen Patienten erreichen. Patient Relations 2015; 15(7):20-21
  • Esser M, Umbach G. Die Planung der Klinikkommunikation mit dem Vierstufenmodell. Management & Krankenhaus 2014; 33(3):6
  • Schreier J, Esser M, Umbach G. Organisation von Advisory Board Meeting und Expertenrunden: Erfolgreich mit der 7-Punkte-Methode. Pharma Relations 2014; 14(12):17
  • Esser M, Guyomard C. Bessere Patientenführung durch gezielten Einsatz von Nozebo- und Plazebokommunikation. Frauenarzt 2013; 54(1):58-59
  • Guyomard C, Esser M. Nozebo- und Plazeboeffekt – Nutzen für die Kommunikation mit Diabetespatienten. Der Diabetologe 2013; 9(5):356-358
  • Esser M, Lang S. Brand Language: Worte mit Wirkung. PM-Report 2013; 1(32):18-20
  • Guyomard C, Esser M. Patientenkommunikaton zwischen Nozebo- und Placeboeffekt. Der Pneumologe 2013; 10(2):134-136
  • Esser M, Lang S. Patientenansprache mit Empathie. Arzneimittelzeitung 2012; 23(7): 20
  • Esser M, Umbach G. Patienteninformation in Zeiten von Informationsinfarkt und Cyberchondrie. PM-Report 2012; 31(10):14-16
  • Esser M, Lang S. Improving patient communication by writing with Empathy. Medical Writing 2012; 21(4): 305-307
  • Esser M, Fuß H. Mobiles Healthcaremarketing: 10 entscheidende Punkte für Konzeption und Umsetzung. Healthcare Marketing 2011; 10(8):64-66
  • Esser M, Riehn J. Storytelling für Healthcare als neuer Trend: Wie Sie die Geschichte Ihres Produkts erzählen und damit Markenbindung aufbauen. PM-eReport 2011; 1(1):1-4
  • Esser M. Medical Education für Patienten: Ein Update. PM-Report 2010; 7(29):18-19
  • Esser M, Lang S. Texte in der Pharmakommunikation. Healthcare Marketing 2010; 7(7):28-30
  • Lang S, Esser M. Writing in science and marketing – Are they really separate worlds? The Write Stuff 2010; 19(3):178-179
  • Esser M, Gianni G. Medical Education auch für Patienten. Healthcare Marketing 2009; Sonderdruck aus 4(6):2-4
  • Esser M. Medical Education: Markttrends und Erfolgsfaktoren. Arzneimittelzeitung 2009; 22(1):9